MicroRNA-21 in cardiovascular disease

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Biomedical Research

Background:

• MicroRNA-21 (miR-21) is highly expressed in the cardiovascular system.
• miR-21 expression is deregulated in various cardiovascular diseases, including vascular disease, cardiac hypertrophy, heart failure, and ischemic heart disease.
• It plays key roles in vascular smooth muscle cell proliferation and apoptosis, cardiac cell growth and death, and cardiac fibroblast functions.

Purpose of the Study:

• To review the current research on the role of miR-21 in cardiovascular disease.
• To highlight miR-21's involvement in the pathogenesis of cardiovascular conditions.
• To discuss miR-21 as a potential therapeutic target for cardiovascular diseases.

Main Methods:

• Review of existing literature on miR-21 and cardiovascular diseases.
• Analysis of studies demonstrating miR-21's function through loss-of-function and gain-of-function approaches.
• Identification of known miR-21 target genes involved in cardiovascular effects.

Main Results:

• miR-21 is implicated in the pathogenesis of proliferative vascular disease, cardiac hypertrophy, heart failure, and ischemic heart disease.
• Identified miR-21 target genes include Programmed cell death 4 (PDCD4), phosphatase and tensin homology deleted from chromosome 10 (PTEN), sprouty1 (SPRY1), and sprouty2 (SPRY2).
• These target genes mediate miR-21's effects on vascular and cardiac cells.

Conclusions:

• miR-21 is a significant factor in cardiovascular disease development.
• Understanding miR-21's mechanisms and targets is crucial for cardiovascular research.
• miR-21 represents a potential novel therapeutic target for cardiovascular diseases.